Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wubiefanchun is a traditional Chinese medicine (TCM) oral liquid formulation developed using modern pharmaceutical technology. It is primarily used in clinical practice for the treatment of premature ovarian failure and related symptoms such as menstrual irregularities, amenorrhea, and hot flashes with sweating. The formula is based on TCM principles of tonifying the liver and kidney, strengthening the spleen and stomach, and regulating Chong-Ren meridians. The product combines characteristics of both medicinal drugs and functional foods. Network pharmacology studies have identified 75 active ingredients in this oral liquid that act on 384 potential targets relevant to its therapeutic effects[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wubiefanchun.